Sec. 38a-542b. Cancer clinical trials: When eligible for coverage.
Sec. 38a-542b. Cancer clinical trials: When eligible for coverage. In order to
be eligible for coverage of routine patient care costs, as defined in section 38a-542d, a
cancer clinical trial shall be conducted under the auspices of an independent peer-reviewed protocol that has been reviewed and approved by: (1) One of the National Institutes of Health; or (2) a National Cancer Institute affiliated cooperative group; or (3)
the federal Food and Drug Administration as part of an investigational new drug or
device exemption; or (4) the federal Department of Defense or Veterans Affairs. Nothing
in sections 38a-542a to 38a-542g, inclusive, shall be construed to require coverage for
any single institution cancer clinical trial conducted solely under the approval of the
institutional review board of an institution, or any trial that is no longer approved by an
entity identified in subdivision (1), (2), (3) or (4) of this section.
(P.A. 01-171, S. 2, 25.)
History: P.A. 01-171 effective January 1, 2002.
See Sec. 38a-504b for similar provisions re individual policies.